Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Short Interest Up 11.8% in September

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLFGet Free Report) saw a large growth in short interest in the month of September. As of September 15th, there was short interest totalling 3,083,800 shares, a growth of 11.8% from the August 31st total of 2,757,700 shares. Based on an average trading volume of 2,300 shares, the days-to-cover ratio is currently 1,340.8 days.

Genomma Lab Internacional Stock Performance

OTCMKTS GNMLF remained flat at $1.13 on Monday. Genomma Lab Internacional has a 12-month low of $0.79 and a 12-month high of $1.13. The business has a 50 day moving average of $1.01 and a two-hundred day moving average of $0.96.

About Genomma Lab Internacional

(Get Free Report)

Genomma Lab Internacional, SAB. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition.

Featured Articles

Receive News & Ratings for Genomma Lab Internacional Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genomma Lab Internacional and related companies with MarketBeat.com's FREE daily email newsletter.